Your browser doesn't support javascript.
loading
Single-nucleus expression characterization of non-enhancing region of recurrent high-grade glioma.
Patel, Kunal S; Tessema, Kaleab K; Kawaguchi, Riki; Dudley, Lindsey; Alvarado, Alvaro G; Muthukrishnan, Sree Deepthi; Perryman, Travis; Hagiwara, Akifumi; Swarup, Vivek; Liau, Linda M; Wang, Anthony C; Yong, William; Geschwind, Daniel H; Nakano, Ichiro; Goldman, Steven A; Everson, Richard G; Ellingson, Benjamin M; Kornblum, Harley I.
Afiliación
  • Patel KS; Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Tessema KK; The Intellectual and Developmental Disabilities Research Center and Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Kawaguchi R; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Dudley L; The Intellectual and Developmental Disabilities Research Center and Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Alvarado AG; The Intellectual and Developmental Disabilities Research Center and Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Muthukrishnan SD; The Intellectual and Developmental Disabilities Research Center and Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Perryman T; Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Hagiwara A; UCLA Brain Tumor Imaging Laboratory (BTIL), Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Swarup V; Department of Neurobiology and Behavior, UCI School of Biological Sciences, Irvine, California, USA.
  • Liau LM; Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Wang AC; Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Yong W; Department of Pathology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Geschwind DH; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Nakano I; Department of Neurosurgery, Hokuto Social Medical Corporation, Hokuto Hospital, Hokuto, Japan.
  • Goldman SA; Center for Translational Neuromedicine, University of Rochester Medical Center, Rochester, New York, USA.
  • Everson RG; Faculty of Health and Medical Sciences, Center for Translational Neuromedicine, University of Copenhagen, Copenhagen, Denmark.
  • Ellingson BM; Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Kornblum HI; Department of Radiation Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Neurooncol Adv ; 6(1): vdae005, 2024.
Article en En | MEDLINE | ID: mdl-38616896
ABSTRACT

Background:

Non-enhancing (NE) infiltrating tumor cells beyond the contrast-enhancing (CE) bulk of tumor are potential propagators of recurrence after gross total resection of high-grade glioma.

Methods:

We leveraged single-nucleus RNA sequencing on 15 specimens from recurrent high-grade gliomas (n = 5) to compare prospectively identified biopsy specimens acquired from CE and NE regions. Additionally, 24 CE and 22 NE biopsies had immunohistochemical staining to validate RNA findings.

Results:

Tumor cells in NE regions are enriched in neural progenitor cell-like cellular states, while CE regions are enriched in mesenchymal-like states. NE glioma cells have similar proportions of proliferative and putative glioma stem cells relative to CE regions, without significant differences in % Ki-67 staining. Tumor cells in NE regions exhibit upregulation of genes previously associated with lower grade gliomas. Our findings in recurrent GBM paralleled some of the findings in a re-analysis of a dataset from primary GBM. Cell-, gene-, and pathway-level analyses of the tumor microenvironment in the NE region reveal relative downregulation of tumor-mediated neovascularization and cell-mediated immune response, but increased glioma-to-nonpathological cell interactions.

Conclusions:

This comprehensive analysis illustrates differing tumor and nontumor landscapes of CE and NE regions in high-grade gliomas, highlighting the NE region as an area harboring likely initiators of recurrence in a pro-tumor microenvironment and identifying possible targets for future design of NE-specific adjuvant therapy. These findings also support the aggressive approach to resection of tumor-bearing NE regions.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Neurooncol Adv Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Neurooncol Adv Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos